The Cancer Letter receives 8 journalism, design awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Cancer Letter received eight 2021 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—five for journalism, and three for illustration.

During a year of reckoning on health equity, gender equality, and systemic racism, as the future of American democracy hung in the balance, The Cancer Letter’s work—recognized by SPJDC—focused on the resonance of Black Lives Matter in oncology, pervasive gender bias at America’s cancer centers, and tracking the impact of COVID-19.

The Cancer Letter’s entries recognized by SPJ include narrative journalism, interviews, surveys, infographics, illustrations and editorial cartoons. This is the second consecutive year The Cancer Letter has won an award for infographics. In a feature about sexual harassment reporting structures, the infographics are central to telling the story, and are recognized as part of the journalism award.

For the fourth consecutive year, The Cancer Letter has won first-place awards for illustration, and the second year The Cancer Letter has won awards for cartooning. The cartoons recognized this year accompany aguest editorial on medical charlatans who attached themselves to Stalin—and Trump. 

The cartoon connects President Donald Trump’s infamous comment on the healing power of household detergents with Joseph Stalin’s championing of the healing power of baking soda.

First-place awards:

Finalist awards:

TCL46-37
TCL46-17
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

VOICES of Black Women, the largest population study of Black women in the United States, will be the first of American Cancer Society’s large-scale population studies to be initiated using an AI-driven data management platform—promising to bring observational cancer research out of the age of Excel data files and email sharing.
Paul Goldberg
Editor & Publisher

Login